Geron (GERN) Equity Income (2010 - 2020)
Geron's (GERN) quarterly Equity Income came in at -$49000.0 in Q4 2020, up 58.47% quarter-over-quarter from -$118000.0 in Q3 2020.
Geron (GERN) Equity Income (2010 - 2020) Analysis & Trends
Geron has disclosed Equity Income across 5 years of filings, most recently posting -$49000.0 for Q4 2020.
- Equity Income for Q4 2020 came in at -$49000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $60000.0 (up 130.77% YoY), and the FY2020 annual result was $60000.0, up 130.77% from the prior year.
- Equity Income came in at -$49000.0 for Q4 2020 at Geron, up from -$118000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of $422000.0 in Q2 2020 to a low of -$350000.0 in Q2 2018.
- The 3-year median for Equity Income is -$118000.0 (2020), against an average of -$61454.5.
- Peak annual rise in Equity Income reached 530.61% in 2020, while the deepest fall reached 298.98% in 2020.
- Geron's Equity Income stood at -$271000.0 in 2018, then increased by 28.04% to -$195000.0 in 2019, then surged by 74.87% to -$49000.0 in 2020.
- The last three Equity Income figures came in at -$49000.0 (Q4 2020), -$118000.0 (Q3 2020), and $422000.0 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Geron | 753,046.88 | 753,046.88 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -49,000.00 |
| Sep 30, 2020 | -118,000.00 |
| Jun 30, 2020 | 422,000.00 |
| Mar 31, 2020 | -195,000.00 |
| Sep 30, 2019 | -195,000.00 |
| Jun 30, 2019 | -98,000.00 |
| Mar 31, 2019 | 98,000.00 |
| Dec 31, 2018 | -271,000.00 |
| Sep 30, 2018 | 205,000.00 |
| Jun 30, 2018 | -350,000.00 |
| Mar 31, 2018 | -125,000.00 |
| Jun 30, 2011 | -168,000.00 |
| Mar 31, 2011 | -335,000.00 |
| Dec 31, 2010 | -1.21 Mn |
| Sep 30, 2010 | -243,000.00 |
| Jun 30, 2010 | -496,000.00 |